Dietary treatment of Crohn’s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey
© The Author(s). 2017
Received: 2 August 2016
Accepted: 22 December 2016
Published: 19 January 2017
Diet is strongly associated with the aetiology of Crohn’s Disease (CD) and exclusive enteral nutrition (EEN) is the primary induction treatment in paediatric CD. This study explored opinions around the use of EEN and alternative novel, solid food-based diets (SFDs) expressed by paediatric patients with CD, previously treated with EEN and their parents.
This anonymous questionnaire surveyed families of CD patients treated with EEN over 1 year. Two questionnaire forms were completed; one asking the patients’ opinions and another referring to their main carer. This questionnaire explored participants’ demographic characteristics; acceptability of a repeat EEN course to treat a future flare (EEN repeat); their opinion on how difficult EEN would be compared to an example SFD; and their intention to participate in a future clinical trial assessing the therapeutic efficacy of an SFD in CD.
Forty-one families of CD patients were approached with 29 sending replies (71%). Most of our participants were positive on completing another EEN course, however the majority would choose an SFD alternative (Patients:66, Parents:72%). Both patients and their parents rated EEN to be more difficult to adhere to compared to an example SFD (p < 0.05), and their ratings were strongly correlated (EEN:r = 0.83, SFD:r = 0.75, p < 0.001). The majority of our respondents would agree to participate in a clinical trial assessing an SFD’s effectiveness (Patients:79, Parents:72%) for the management of active CD.
While patients with CD and their families would accept an EEN repeat, the majority would prefer an SFD alternative. CD families surveyed are supportive of the development of solid food-based dietary treatments.
KeywordsCrohn’s disease Exclusive enteral nutrition Dietary therapy Diet Perceptions
Crohn’s disease (CD) is an incurable chronic inflammatory condition of the gut. It causes severe gastrointestinal and extraintestinal complications and is associated with high morbidity, poor quality of life and increased health expenditure .
The medical treatment for induction and maintenance of CD remission includes anti-inflammatory and immunomodulatory medication , whereas exclusive enteral nutrition (EEN) is established as the primary induction treatment in paediatric CD. EEN induces both mucosal and transmural healing, has up to 80% remission rates and an excellent safety profile . It is however potentially restrictive and can be difficult to adhere to for long periods of time with compliance and palatability issues limiting its use especially in adult patients .
The strong and sustained patient interest on the role of diet in CD has been described in the literature . This is also reflected by the high usage of complementary and alternative medicine among CD patients, with dietary modifications being among the most common therapies used . Additionally, emerging evidence is indicating potential clinical efficacy of exclusion solid food-based diets (SFDs) [7–13].
These facts pose a pressing need and clinical demand to explore patients’ perceptions on the use of EEN and the introduction of novel SFDs for use in routine clinical practice. The aim of this questionnaire survey was therefore to report the beliefs of carers and paediatric CD patients, previously treated with EEN, on the acceptability of such dietary treatments, including within a research context.
Recruitment of families with CD children
An anonymous questionnaire survey was posted to all families of paediatric CD patients who had been treated with a previously described EEN protocol  during 2015 by the IBD team at the Royal Hospital for Children in Glasgow (RHCG). Two questionnaire forms were included: one asking the patients’ opinions and another referring to their main carer (hereafter “parent”). A stamped addressed envelope was provided for the return of the questionnaires and a reminder was sent out 2 months later to increase response rate. Both the initial posted envelope and the reminder included a cover letter explaining the reason of this questionnaire survey, but also instructing the parents and patients to complete the questionnaires separately (see Additional file 1).
A draft questionnaire was compiled by senior medical and dietetic staff who look after patients with CD. The content validity of the survey was then checked by members of the IBD team at RHCG and its readability by lay people (see Additional files 2 and 3). The survey collected information on participants’ demographic characteristics, the acceptability of an EEN repeat, and their opinion on how difficult it was to undertake an EEN course or it would be to undertake an example SFD provided to them (using visual analogue scales, translated to a scale from 1 to 100; see Q7 and Q13 of Additional file 2). It also investigated their intention to participate in a future clinical trial assessing the therapeutic efficacy of an SFD in CD. The questions asked included both open-ended and multiple-choice and we explicitly asked the participants for any further comments on their previous EEN experience or the use of an SFD. These comments were categorised as positive, negative or neutral by the investigators. The SFD was a diet template (see Additional files 2 and 3) describing an alternative exclusion diet. We ensured that no specific dietary advice was disclosed in this example template and made a specific statement on this matter.
Recruitment of adult CD patients
Following the same approach as described above we identified adult CD patients, treated with EEN by the IBD team at the Glasgow Royal Infirmary in Glasgow.
Categorical responses are presented with numbers and frequencies (%). Differences between ratings of the two diets by the participants were compared with 1-sample Wilcoxon signed-rank test. Correlations of parents’ and patients’ ratings were tested with Spearman’s rank correlation. Statistical analysis was performed with Minitab 16 (Minitab Ltd, Coventry, UK) and IBM SPSS Statistics 20 (IBM Corp, Armonk, NY).
Response rate, demographic characteristics and exclusive enteral nutrition experience characteristics of paediatric Crohn’s disease participants
29 out of 41 (71)
Parental IBD history
Completed 8 weeks EEN
Experienced EEN once
Repeated EEN courses
Use of NG tube
Median Age (IQR)
Frequencies of answers by paediatric CD patients and their parents (%Yes_%No_%n/a)
Total answers n = 29
n = 6
n = 23
n = 13
Use of NG tube
n = 16
If you/your child had a further flare-up of CD, do you think you/they could complete another LD course?
Do you think an SFD would be better than the LD?
Would you be happy to participate in such a study if doctors felt you/they needed a repeat of the LD?
Would you/your child take the SFD beyond 8w if it was effective and meant less medication?
Almost two thirds of the patients and their parents (n = 17; 59%) were positive on completing another EEN course in the event of a future relapse, however a higher proportion of participants thought an SFD would be better than EEN (Patients: n = 19; 66%, Parents: 21; 72%) (Table 2).
Participants generally agreed that if they needed to undertake a further EEN course in a future relapse of their disease, they would agree to participate in a clinical trial comparing EEN with an SFD (Patients: n = 23; 79%, Parents: n = 21; 72%). When we explained further the design of a hypothetical RCT, and reported that the development of a new dietary treatment could decrease medication exposure, these percentages remained equally high (Patients: n = 25; 86%, Parents: n = 20; 69%) (Table 2).
To further explore these data, we split each of the patient and parent groups into 4 further subgroups based on whether they completed their previous EEN course or not and whether they used an NG tube during treatment or not. This subanalysis revealed that participants who failed treatment generally had a negative attitude to an EEN repeat. In addition, participants who didn’t use an NG tube had a more positive attitude towards the use of an SFD (Table 2).
Regarding the adult CD patients previously treated with EEN over 1 year, 10 were identified of whom only 3 responded after the reminder letter. The responders’ perceptions towards the use of an SFD were similarly positive to those of CD families but these data are not presented due to the very low response rate.
This survey delivers important insights on the EEN experience for families of children with CD and explores the acceptability of an alternative hypothetical SFD. The large majority of our participants would be happy to repeat an EEN course during a further relapse of their disease. This indicates that both patients and their carers recognise the efficacy of EEN in CD management. The modern use of more palatable polymeric feeds, and the experience and training of health care professionals involved in administering the treatment are known factors increasing the acceptability of EEN [15, 16].
Despite the positive attitude to the use of EEN, most respondents would preferentially agree to use an alternative SFD. The existing literature, describing patients’ frequent requests for dietary advice and exclusion of certain foods to prevent future relapses, is supportive of the idea that an SFD would be well-received [17, 18].
CD patient perceptions were not different and strongly correlated to those of their parents. This strong agreement between parents and their chronically ill children has been reported before ; however, there are strong arguments that both opinions are of vital importance and should be sought jointly .
The present survey is not without its limitations. Our participants were asked to compare two different dietary treatments, having experienced only the EEN before. They therefore had to provide a hypothetical view on an SFD, based on a provided exclusion diet template. Additionally, only paediatric data are presented in the current publication due to the poor response rate (30%) in the adult CD patients approached for the reasons of this survey. EEN use in adult CD patients is not a standard practice due to limited evidence of its efficacy in historical datasets. Poor compliance mainly explained by palatability issues is reported as the main reason for this . The low response rate among these patients could be explained by their disease status, as according to the current guidelines EEN use in adults is biased towards patients with drug resistance or used as an adjunctive therapy [21, 22]. Another potential source of bias is the EEN completion rate within the 12 patients (29% non-respondents) who did not return their questionnaires. Lack of disease response on EEN course may differ between respondents and non-respondents and this was not specifically examined in this cohort. The EEN completion rate within the 29 families included in our results (79%) however is in broad agreement with previously published rates from the same centre (75%), suggesting a similar group .
In conclusion, surveyed CD patients and their parents are generally happy to repeat a course of EEN if needed, though unsurprisingly this enthusiasm falls with previous EEN failure. Additionally, CD families surveyed are supportive of the development and study of solid food-based dietary treatments. This fits nicely with a well-described desire for dietary modifications amongst the IBD patient community and lends support towards developing a new paradigm of CD dietary therapy, based on the success of EEN.
Exclusive enteral nutrition
Inflammatory bowel disease
Solid food-based diets
The authors wish to thank the participants and their families, the IBD team at the Royal Hospital for Children in Glasgow and the IBD team at the Glasgow Royal Infirmary.
The authors are supported by the Glasgow Children’s Hospital Charity and the Catherine McEwan Foundation.
Availability of data and materials
All data generated and analysed during this study are included in this published article as an additional. xlxs file (Additional file 4).
VS collated the data, performed statistical analysis and drafted the manuscript; EB, LC, VG, JH, SL, JM, DRG, RKR gave clinical input, identified eligible participants, and helped design the questionnaire; KG, RH conceived, co-ordinated and designed the study and helped draft and revise the manuscript. All authors revised and approved the final draft for submission.
RH, RKR and DRG are supported by NHS Research Scotland Career Researcher Fellowships. KG has received speaker’s fees, travel support and research grants from Nutricia and/or Nestle. RKR has received speaker’s fees, travel support, and/or participated in medical board meetings with Nestle, MSD Immunology, AbbVie, Dr Falk, Takeda, Napp, Mead Johnson, Nutricia & 4D Pharma. DRG has received honoraria for educational meetings from MSD, AbbVie, Takeda & Ferring. RH has received speaker’s fees, travel support, and/or participated in medical board meetings with MSD Immunology, Dr Falk, Nutricia & 4D Pharma.
Consent for publication
Ethics approval and consent to participate
According to the NHS Research Ethics Service guidance  no ethical review permission was required for this anonymous clinical survey appraising patients’ opinions on current management approaches and the possibility of introducing novel alternative treatments for routine clinical practice.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Shanahan F. Crohn’s disease. Lancet. 2002;359(9300):62–9.View ArticlePubMedGoogle Scholar
- Cummings JR, Keshav S, Travis SP. Medical management of Crohn’s disease. BMJ. 2008;336(7652):1062–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J crohns colitis. 2014;8(10):1179–207.View ArticlePubMedGoogle Scholar
- Wall CL, Day AS, Gearry RB. Use of exclusive enteral nutrition in adults with Crohn’s disease: a review. World j gastroenterol. 2013;19(43):7652–60.View ArticlePubMedPubMed CentralGoogle Scholar
- Inflammatory Bowel Disease (IBD) Research Priorities from IBD Priority Setting Partnership 2015, James Lind Alliance Priority Setting Partnerships, http://www.jla.nihr.ac.uk/priority-setting-partnerships/inflammatory-bowel-disease. Accessed 25 July 2016.
- Gerasimidis K, Mcgrogan P, Hassan K, Edwards CA. Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Aliment pharmacol ther. 2008;27(2):155–65.View ArticlePubMedGoogle Scholar
- Brotherton CS, Taylor AG, Bourguignon C, Anderson JG. A high-fiber diet may improve bowel function and health-related quality of life in patients with Crohn disease. Gastroenterol nurs. 2014;37(3):206–16.View ArticlePubMedPubMed CentralGoogle Scholar
- Olendzki BC, Silverstein TD, Persuitte GM, Ma Y, Baldwin KR, Cave D. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr j. 2014;13:5.View ArticlePubMedPubMed CentralGoogle Scholar
- Rajendran N, Kumar D. Food-specific IgG4-guided exclusion diets improve symptoms in Crohn’s disease: a pilot study. Colorectal dis. 2011;13(9):1009–13.View ArticlePubMedGoogle Scholar
- Obih C, Wahbeh G, Lee D, Braly K, Giefer M, Shaffer ML, Nielson H, Suskind DL. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2016;32(4):418–25.View ArticlePubMedGoogle Scholar
- Prince AC, Myers CE, Joyce T, Irving P, Lomer M, Whelan K. Fermentable carbohydrate restriction (Low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm bowel dis. 2016;22(5):1129–36.View ArticlePubMedGoogle Scholar
- Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn’s disease exclusion diet is effective for induction of remission in children and young adults with Crohn’s disease. Inflamm bowel dis. 2014;20(8):1353–60.View ArticlePubMedGoogle Scholar
- Hwang C, Ross V, Mahadevan U. Popular exclusionary diets for inflammatory bowel disease: the search for a dietary culprit. Inflamm bowel dis. 2014;20(4):732–41.View ArticlePubMedGoogle Scholar
- Buchanan E, Gaunt WW, Cardigan T, Garrick V, Mcgrogan P, Russell RK. The use of exclusive enteral nutrition for induction of remission in children with Crohn’s disease demonstrates that disease phenotype does not influence clinical remission. Aliment pharmacol ther. 2009;30(5):501–7.View ArticlePubMedGoogle Scholar
- Kansal S, Wagner J, Kirkwood CD, Catto-Smith AG. Enteral nutrition in Crohn’s disease: an underused therapy. Gastroenterol res pract. 2013;2013:482108.View ArticlePubMedPubMed CentralGoogle Scholar
- Rodrigues AF, Johnson T, Davies P, Murphy MS. Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn’s disease? Arch dis child. 2007;92(9):767–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm bowel dis. 2016;22(1):164–70.View ArticlePubMedGoogle Scholar
- Zallot C, Quilliot D, Chevaux JB, Peyrin-Biroulet C, Gueant-Rodriguez RM, Freling E, Collet-Fenetrier B, Williet N, Ziegler O, Bigard MA, et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm bowel dis. 2013;19(1):66–72.View ArticlePubMedGoogle Scholar
- le Coq EM, Boeke AJ, Bezemer PD, Colland VT, van Eijk JT. Which source should we use to measure quality of life in children with asthma: the children themselves or their parents? Qual life res int j qual life aspects treat care rehabil. 2000;9(6):625–36.View ArticleGoogle Scholar
- Eiser C, Morse R. Can parents rate their child’s health-related quality of life? results of a systematic review. Qual life res int j qual life aspects treat care rehabil. 2001;10(4):347–57.View ArticleGoogle Scholar
- Dignass A, Van Assche G, Lindsay JO, Lemann M, Soderholm J, Colombel JF, Danese S, D’Hoore A, Gassull M, Gomollon F, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. J crohns colitis. 2010;4(1):28–62.View ArticlePubMedGoogle Scholar
- Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn’s disease in adults. Am j gastroenterol. 2009;104(2):465–83. quiz 464, 484.View ArticlePubMedGoogle Scholar
- Defining Research, Research Ethics Service guidance to help you decide if your project requires review by a Research Ethics Committee. London: © Health Research Authority. Ref: 0987 December 2009 (rev. April 2013; June 2016). http://www.hra.nhs.uk/documents/2016/06/defining-research.pdf.